Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    HEPARIN SODIUM 10,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,480Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    29/11/2025 Changzhou SPL Company, Ltd
    China
    		 Changzhou SPL Company, Ltd Wujin, Changzhou City CN R0-CEP 2004-080 - Rev 00 Heparin sodium, Potency not less than 150 IU/mg (with reference to the dried substance) From porcine origin, Bacterial Endotoxin Free 2005-08-03 Withdrawn by Holder Chemical 2009-03-10 333
    29/11/2025 HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.
    China
    		 HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. Shijiazhuang CN CEP 2005-270 - Rev 13 Heparin sodium 2025-09-12 Valid Chemical 333